OrbiMed Capital GP IV LLC
Insider CIK 1502240 · ICPT Director, 10% owner · ANTH Director · RLYP 10% owner · OTIC Director, 10% owner · ASNS 10% owner · PRNB 10% owner · AFIB Director, 10% owner · TELA 10% owner · MRTX 10% owner · BOLD 10% owner · ALEC Director, 10% owner · ARMO Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TELA TELA Bio, Inc. | S Sale | 2024-07-02 | 2024-07-02 | 36,600 | $4.54 | $166.2K | 2,407,242 | SEC↗ |
| TELA TELA Bio, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 13,700 | $4.68 | $64.1K | 2,443,842 | SEC↗ |
| TELA TELA Bio, Inc. | S Sale | 2024-06-28 | 2024-07-02 | 378,000 | $4.74 | $1.79M | 2,457,542 | SEC↗ |
| TELA TELA Bio, Inc. | S Sale | 2023-04-21 | 2023-04-21 | 27,700 | $9.41 | $260.7K | 2,835,542 | SEC↗ |
| TELA TELA Bio, Inc. | S Sale | 2023-04-20 | 2023-04-21 | 28,300 | $9.43 | $266.9K | 2,863,242 | SEC↗ |
| TELA TELA Bio, Inc. | S Sale | 2023-04-19 | 2023-04-21 | 136,000 | $9.30 | $1.26M | 2,891,542 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 357,143 | $14.00 | $5.00M | 1,677,361 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 714,285 | $14.00 | $10.00M | 4,872,025 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 378,733 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,202,117 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 389,116 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 899,985 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 647,582 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 673,123 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 872,302 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 41,500 | $18.00 | $747.0K | 41,500 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 373,500 | $18.00 | $6.72M | 373,500 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 1,278,718 | — | $0 | 1,320,218 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 3,784,240 | — | $0 | 4,157,740 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-16 | 2020-04-16 | 15,086 | $23.53 | $355.0K | 1,906,718 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-16 | 2020-04-16 | 47,097 | $23.53 | $1.11M | 5,955,674 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-14 | 2020-04-16 | 17,595 | $23.52 | $413.8K | 6,002,771 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-14 | 2020-04-16 | 5,636 | $23.52 | $132.6K | 1,921,804 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-09 | 2020-04-09 | 69,893 | $23.79 | $1.66M | 1,927,440 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-09 | 2020-04-09 | 218,208 | $23.79 | $5.19M | 6,020,366 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-08 | 2020-04-09 | 20,041 | $23.65 | $474.0K | 1,997,333 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-08 | 2020-04-09 | 62,573 | $23.65 | $1.48M | 6,238,574 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-07 | 2020-04-09 | 2,224 | $23.10 | $51.4K | 2,017,374 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-04-07 | 2020-04-09 | 6,946 | $23.10 | $160.5K | 6,301,147 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-31 | 2020-04-02 | 60,645 | $24.50 | $1.49M | 2,019,598 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-31 | 2020-04-02 | 189,355 | $24.50 | $4.64M | 6,308,093 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-25 | 2020-03-25 | 13,684 | $24.66 | $337.4K | 2,080,243 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-25 | 2020-03-25 | 42,727 | $24.66 | $1.05M | 6,497,448 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-24 | 2020-03-25 | 16,409 | $24.45 | $401.2K | 2,093,927 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-24 | 2020-03-25 | 51,235 | $24.45 | $1.25M | 6,540,175 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-23 | 2020-03-25 | 11,057 | $26.05 | $288.0K | 6,591,410 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-23 | 2020-03-25 | 3,541 | $26.05 | $92.2K | 2,110,336 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 38,808 | $26.00 | $1.01M | 0 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 445,086 | $26.00 | $11.57M | 2,113,877 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 1,390,309 | $26.00 | $36.15M | 6,602,467 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-01-09 | 2020-01-13 | 286,787 | $19.50 | $5.59M | 7,992,776 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-01-09 | 2020-01-13 | 91,818 | $19.50 | $1.79M | 2,558,963 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-01-09 | 2020-01-13 | 1,392 | $19.50 | $27.1K | 38,808 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-26 | 2019-12-26 | 2,325 | $18.60 | $43.2K | 2,650,781 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-26 | 2019-12-26 | 7,275 | $18.60 | $135.3K | 8,279,563 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-26 | 2019-12-26 | 1,200 | $18.60 | $22.3K | 40,200 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-24 | 2019-12-26 | 8,000 | $19.59 | $156.7K | 41,400 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-24 | 2019-12-26 | 15,476 | $19.59 | $303.2K | 2,653,106 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-24 | 2019-12-26 | 48,324 | $19.59 | $946.7K | 8,286,838 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-23 | 2019-12-26 | 20,350 | $19.82 | $403.3K | 2,668,582 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-23 | 2019-12-26 | 10,400 | $19.82 | $206.1K | 49,400 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-23 | 2019-12-26 | 63,535 | $19.82 | $1.26M | 8,335,162 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 230,721 | $19.66 | $4.54M | 8,398,697 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 73,879 | $19.66 | $1.45M | 2,688,932 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 37,900 | $19.66 | $745.1K | 59,800 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-17 | 2019-12-19 | 205,793 | $18.52 | $3.81M | 2,762,811 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-17 | 2019-12-19 | 642,807 | $18.52 | $11.90M | 8,629,418 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-17 | 2019-12-19 | 105,500 | $18.52 | $1.95M | 97,700 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 758,623 | — | $0 | 758,623 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 11,878,249 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 758,623 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 24,142,419 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 481,095 | — | $0 | 2,049,722 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 977,820 | — | $0 | 3,027,542 | SEC↗ |
| TELA TELA Bio, Inc. | P Buy | 2019-11-08 | 2019-11-13 | 384,615 | $13.00 | $5.00M | 1,568,627 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-08-07 | 2019-08-09 | 492,364 | $17.90 | $8.81M | 9,272,225 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-08-07 | 2019-08-09 | 157,636 | $17.90 | $2.82M | 2,968,604 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-05-21 | 2019-05-22 | 1,000,000 | $30.25 | $30.25M | 1,605,713 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 405,925 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 94,075 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 992,437 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 2,029,626 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 470,374 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 2,280,479 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 528,510 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 1,012,282 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 234,601 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 266,437 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 85,295 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 4,282,288 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | P Buy | 2019-02-11 | 2019-02-11 | 157,939 | $19.00 | $3.00M | 10,434,976 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 94,075 | — | $0 | 94,075 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 470,374 | — | $0 | 1,556,886 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 266,437 | — | $0 | 10,277,037 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 1,012,282 | — | $0 | 10,010,600 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 2,280,479 | — | $0 | 8,998,318 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 2,029,626 | — | $0 | 6,717,839 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 4,282,288 | — | $0 | 4,688,213 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 405,925 | — | $0 | 405,925 | SEC↗ |
| ALEC Alector, Inc. | P Buy | 2019-02-11 | 2019-02-11 | 203,200 | $19.00 | $3.86M | 203,200 | SEC↗ |
| ALEC Alector, Inc. | P Buy | 2019-02-11 | 2019-02-11 | 50,561 | $19.00 | $960.7K | 2,455,853 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 85,295 | — | $0 | 2,405,292 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 234,601 | — | $0 | 2,319,997 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 528,510 | — | $0 | 2,085,396 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 992,437 | — | $0 | 1,086,512 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 1,070,771 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 312,741 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 544,047 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 260,617 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 2,355,713 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 544,047 | — | $0 | 2,188,176 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 260,617 | — | $0 | 1,644,129 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 312,741 | — | $0 | 1,383,512 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 1,070,771 | — | $0 | 1,070,771 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2018-09-18 | 2018-09-20 | 250,000 | $17.00 | $4.25M | 2,605,713 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | U Tender | 2018-06-22 | 2018-06-22 | 3,709,356 | $50.00 | $185.47M | 3,709,356 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | U Tender | 2018-06-22 | 2018-06-22 | 409,547 | $50.00 | $20.48M | 409,547 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-12 | 2018-03-12 | 16,937 | $34.92 | $591.4K | 3,539,997 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-12 | 2018-03-12 | 1,066 | $36.04 | $38.4K | 3,556,934 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-09 | 2018-03-12 | 11,305 | $36.44 | $412.0K | 3,558,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-09 | 2018-03-12 | 47,395 | $35.86 | $1.70M | 3,569,305 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-09 | 2018-03-12 | 21,300 | $34.67 | $738.5K | 3,616,700 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-08 | 2018-03-12 | 58,428 | $34.06 | $1.99M | 3,638,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-06 | 2018-03-06 | 11,372 | $33.03 | $375.6K | 3,696,428 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-05 | 2018-03-06 | 200 | $36.06 | $7.2K | 3,707,800 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-02 | 2018-03-06 | 386,080 | $35.06 | $13.54M | 3,743,558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-02 | 2018-03-06 | 35,558 | $36.33 | $1.29M | 3,708,000 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,783,704 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,226,156 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 415,869 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 283,627 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 332,271 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 45,961 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 31,315 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 409,547 | — | $0 | 409,547 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 3,709,356 | — | $0 | 3,709,356 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 2,232,014 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 736,648 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 704,846 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 66,667 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 229,412 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 328,909 | — | $0 | 600,672 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 500,000 | $10.00 | $5.00M | 1,868,966 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 19,533 | — | $0 | 19,533 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 252,230 | — | $0 | 271,763 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 114,320 | — | $0 | 714,992 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 653,974 | — | $0 | 1,368,966 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 672,000 | $28.25 | $18.98M | 4,129,638 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | X Exercise deriv | 2017-09-07 | 2017-09-11 | 5,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | X Exercise | 2017-09-07 | 2017-09-11 | 5,000 | $15.03 | $75.2K | 4,806,638 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-07 | 2017-09-11 | 5,000 | $22.35 | $111.8K | 4,801,638 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2016-07-25 | 2016-07-26 | 343,600 | $31.98 | $10.99M | 3,356,400 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2016-07-22 | 2016-07-26 | 3,700,000 | $32.00 | $118.40M | 3,700,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-23 | 2015-12-23 | 52,058 | $27.54 | $1.43M | 7,400,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-23 | 2015-12-23 | 47,942 | $26.78 | $1.28M | 7,452,058 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-22 | 2015-12-23 | 111,370 | $26.39 | $2.94M | 7,538,630 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-22 | 2015-12-23 | 38,630 | $27.02 | $1.04M | 7,500,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-21 | 2015-12-23 | 235,829 | $27.50 | $6.49M | 7,664,171 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-21 | 2015-12-23 | 14,171 | $28.39 | $402.3K | 7,650,000 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-30 | 2015-11-30 | 590 | $29.22 | $17.2K | 1,850,094 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-30 | 2015-11-30 | 2,716 | $28.64 | $77.8K | 1,850,684 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-27 | 2015-11-30 | 29,000 | $28.97 | $840.1K | 1,853,400 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-25 | 2015-11-30 | 34,800 | $28.91 | $1.01M | 1,882,400 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-24 | 2015-11-24 | 36,100 | $28.75 | $1.04M | 1,917,200 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-23 | 2015-11-24 | 80,800 | $28.45 | $2.30M | 1,953,300 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-20 | 2015-11-24 | 83,900 | $28.59 | $2.40M | 2,034,100 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-19 | 2015-11-19 | 127,300 | $28.60 | $3.64M | 2,118,000 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-17 | 2015-11-19 | 10,898 | $28.80 | $313.9K | 2,245,500 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-17 | 2015-11-19 | 200 | $29.09 | $5.8K | 2,245,300 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2015-10-22 | 2015-10-22 | 310,700 | $12.92 | $4.01M | 7,900,000 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2015-10-22 | 2015-10-22 | 189,300 | $11.97 | $2.27M | 7,589,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-07-17 | 2015-07-21 | 285 | — | $0 | 1,120,609 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-05-18 | 2015-05-20 | 1,457,551 | $34.13 | $49.75M | 7,400,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 6,000 | $292.13 | $1.75M | 1,122,914 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 3,700 | $291.12 | $1.08M | 1,128,914 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 13,974 | $290.02 | $4.05M | 1,132,614 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 15,131 | $289.07 | $4.37M | 1,146,588 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 26,028 | $288.11 | $7.50M | 1,161,719 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 18,041 | $287.16 | $5.18M | 1,187,747 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 7,611 | $286.24 | $2.18M | 1,205,788 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 23,903 | $285.18 | $6.82M | 1,213,399 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 16,845 | $284.20 | $4.79M | 1,237,302 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 9,357 | $282.87 | $2.65M | 1,254,147 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 2,500 | $293.85 | $734.6K | 1,120,414 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 90 | $294.82 | $26.5K | 1,120,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 8,397 | $282.13 | $2.37M | 1,263,504 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 5,623 | $281.11 | $1.58M | 1,271,901 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-25 | 2,800 | $270.23 | $756.6K | 1,277,524 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 6,764 | $268.13 | $1.81M | 1,319,160 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 1,539 | $269.10 | $414.1K | 1,317,621 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 9,574 | $270.13 | $2.59M | 1,308,047 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 6,063 | $271.15 | $1.64M | 1,301,984 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 3,050 | $272.13 | $830.0K | 1,298,934 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 2,700 | $273.19 | $737.6K | 1,296,234 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 12,066 | $275.00 | $3.32M | 1,284,168 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 3,844 | $275.56 | $1.06M | 1,280,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 9,465 | $280.00 | $2.65M | 1,339,730 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 6,306 | $281.01 | $1.77M | 1,333,424 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 3,500 | $282.00 | $987.0K | 1,329,924 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 1,548 | $283.29 | $438.5K | 1,328,376 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 52 | $283.44 | $14.7K | 1,328,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 1,400 | $286.04 | $400.5K | 1,326,924 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 1,000 | $288.60 | $288.6K | 1,325,924 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 40,598 | $270.70 | $10.99M | 1,444,726 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 7,764 | $271.70 | $2.11M | 1,436,962 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 8,638 | $272.79 | $2.36M | 1,428,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 11,869 | $273.89 | $3.25M | 1,416,455 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 3,579 | $274.86 | $983.7K | 1,412,876 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 37,666 | $275.95 | $10.39M | 1,375,210 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 8,195 | $276.96 | $2.27M | 1,367,015 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 14,152 | $278.00 | $3.93M | 1,352,863 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 3,668 | $279.00 | $1.02M | 1,349,195 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-02-03 | 2015-02-05 | 100,000 | $20.00 | $2.00M | 1,267,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-09-17 | 2014-09-18 | 49,000 | $25.07 | $1.23M | 8,857,551 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-09-16 | 2014-09-18 | 42,400 | $25.45 | $1.08M | 8,909,151 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-09-16 | 2014-09-18 | 2,600 | $26.06 | $67.8K | 8,906,551 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 10,400 | $299.13 | $3.11M | 1,536,182 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 45,058 | $300.11 | $13.52M | 1,491,124 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 5,400 | $301.36 | $1.63M | 1,485,724 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 400 | $302.34 | $120.9K | 1,485,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 12,558 | $294.67 | $3.70M | 1,584,024 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 25,442 | $295.52 | $7.52M | 1,558,582 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 10,010 | $296.59 | $2.97M | 1,548,572 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 1,990 | $297.26 | $591.5K | 1,546,582 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 1,706,484 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 378,039 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-19 | 2,084,523 | — | $0 | 2,084,523 | SEC↗ |
| OTIC Otonomy, Inc. | P Buy | 2014-08-18 | 2014-08-19 | 171,875 | $16.00 | $2.75M | 2,256,398 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-08-15 | 2014-08-19 | 990,000 | $26.35 | $26.09M | 8,951,551 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 350 | $308.13 | $107.8K | 1,596,582 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 6,192 | $296.86 | $1.84M | 1,631,902 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 7,062 | $296.21 | $2.09M | 1,638,094 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 3,704 | $292.70 | $1.08M | 1,652,878 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 4,468 | $293.85 | $1.31M | 1,648,410 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 3,254 | $294.96 | $959.8K | 1,645,156 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 14,640 | $307.06 | $4.50M | 1,596,932 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 525 | $306.23 | $160.8K | 1,611,572 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,732 | $305.14 | $528.5K | 1,612,097 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,193 | $303.77 | $362.4K | 1,613,829 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,100 | $302.55 | $332.8K | 1,615,022 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,710 | $301.42 | $515.4K | 1,616,122 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 3,985 | $300.21 | $1.20M | 1,617,832 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 100 | $298.61 | $29.9K | 1,621,817 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 9,985 | $297.76 | $2.97M | 1,621,917 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-08-09 | 2014-08-11 | 324 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-08-09 | 2014-08-11 | 324 | — | $0 | 1,656,582 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2014-07-01 | 2014-07-01 | 5,000 | $20.04 | $100.2K | 1,167,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2014-06-30 | 2014-07-01 | 4,717 | $21.11 | $99.6K | 1,172,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2014-06-30 | 2014-07-01 | 9,283 | $20.33 | $188.7K | 1,176,717 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2014-06-27 | 2014-07-01 | 79,120 | $21.79 | $1.72M | 1,195,212 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2014-06-27 | 2014-07-01 | 9,212 | $23.09 | $212.7K | 1,186,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-05-09 | 2014-05-09 | 325 | — | $0 | 1,656,258 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-05-07 | 2014-05-09 | 1,330 | — | $0 | 1,655,933 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-04-09 | 2014-04-11 | 81,305 | $320.00 | $26.02M | 1,654,603 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-02-09 | 2014-02-11 | 324 | — | $0 | 649 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-02-09 | 2014-02-11 | 324 | — | $0 | 1,735,908 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 327,133 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 327,133 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 1,417,578 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 1,417,578 | — | $0 | 1,417,578 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 1,417,578 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 327,133 | — | $0 | 327,133 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 693,991 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 3,007,297 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 1,905,702 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 1,295,845 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2013-11-20 | 2013-11-20 | 712,192 | $11.00 | $7.83M | 9,941,551 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 5,116 | $11.00 | $56.3K | 9,229,359 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 327,133 | $0.17 | $55.6K | 9,234,475 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 22,166 | $11.00 | $243.8K | 8,907,342 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 1,417,578 | $0.17 | $241.0K | 8,929,508 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 693,991 | — | $0 | 7,511,930 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 3,007,297 | — | $0 | 6,817,939 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 1,905,702 | — | $0 | 3,810,642 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 1,904,940 | — | $0 | 1,904,940 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-11-09 | 2013-11-12 | 325 | — | $0 | 973 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-11-09 | 2013-11-12 | 325 | — | $0 | 1,735,584 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2013-10-29 | 2013-10-31 | 125,000 | $17.50 | $2.19M | 1,274,332 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-21 | 2013-10-23 | 40,088 | $62.50 | $2.51M | 1,735,259 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-15 | 2013-10-17 | 376,585 | $62.50 | $23.54M | 1,775,347 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-08-09 | 2013-08-13 | 325 | — | $0 | 1,298 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-08-09 | 2013-08-13 | 325 | — | $0 | 2,151,932 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-09 | 2014-05-09 | 325 | — | $0 | 324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-09 | 2013-05-13 | 324 | — | $0 | 1,623 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-09 | 2013-05-13 | 324 | — | $0 | 2,151,607 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-07 | 2014-05-09 | 1,330 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-04-09 | 2013-04-15 | 649 | — | $0 | 1,947 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-04-09 | 2013-04-15 | 649 | — | $0 | 2,151,283 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2013-01-30 | 2013-02-01 | 5,700,000 | $0.66 | $3.76M | 7,462,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2013-01-25 | 2013-01-29 | 1,762,000 | $0.65 | $1.15M | 1,762,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion deriv | 2012-10-16 | 2012-10-16 | 10,500,000 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion | 2012-10-16 | 2012-10-16 | 1,817,300 | — | $0 | 1,817,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | P Buy | 2012-10-16 | 2012-10-16 | 333,334 | $15.00 | $5.00M | 2,150,634 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-06-29 | 2012-07-03 | 1,283,300 | $0.73 | $936.8K | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-03-22 | 2012-03-22 | 1,306,700 | $2.40 | $3.14M | 1,283,300 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-03-21 | 2012-03-22 | 125,000 | $2.87 | $358.8K | 2,590,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-03-20 | 2012-03-22 | 116,800 | $2.90 | $338.7K | 2,715,000 | SEC↗ |